Brineura

BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug
CNBC
Sun, 04/30/17 - 12:51 pm
Biomarin
Brineura
drug pricing
Batten disease
4 Drug Stocks With Big News Coming in April
Motley Fool
Tue, 04/4/17 - 12:11 am
Neurocrine
Incyte
Eli Lilly
Biomarin
Ingrezza
baricitinib
Brineura
BioMarin hits snag with latest rare disease drug
BioPharma Dive
Wed, 09/7/16 - 08:34 pm
Biomarin
Brineura
FDA
CLN2 disease